Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Condition: Overactive Bladder Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Benign Prostatic Hyperplasia | Overactive Bladder | Overactive Bladder Syndrome | Research | Study